Abbott Receives FDA Approval for Gallant Heart Rhythm Implants Featuring Continuous Remote Monitoring

Abbott FDA Approval Gallant Heart Rhythm Implants
Entrance to Abbott Ireland at Cootehill (Image credit: Eric Jones, via geograph)
Abbott won FDA approval for its next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. Cleared in Europe earlier this year, the implants feature Bluetooth connectivity, allowing data to stream to a physician for closer observation and monitoring. Read more Abbott’s Freestyle Libre 2 iCGM Receives FDA Clearance For Adults And […]
To access this post, you must purchase Free Subscription, Premium Abo or Premium Abo (6 months).